Results 71 to 80 of about 10,506 (181)

Infección por Lophomonas blattarum en un paciente sin factores de riesgo identificados: Reporte de caso

open access: yesRevista Alergia México
Antecedentes: La infección pulmonar por Lophomonas blattarum es una infestación poco frecuente en pacientes sanos. En México se ha reportado esta enfermedad solo en pacientes inmunodeprimidos.
Luisa Paulina P. Lozano   +2 more
doaj   +1 more source

Diagnóstico de las enfermedades respiratorias no tuberculosas

open access: yesAnales de la Facultad de Medicina, 2014
Hasta hace aproximadamente dos décadas, el primer diagnóstico para las afecciones bronco-pulmonares de evolución prolongada generalmente era de tuberculosis, luego, se consideraba en el diagnóstico diferencial una extensa lista de afecciones respiratorias no tuberculosas.
openaire   +2 more sources

Temporal trend of mortality from infectious respiratory diseases in childhood in Minas Gerais, Brazil, 2000-2020. [PDF]

open access: yesEpidemiol Serv Saude, 2023
Moura DNAE   +6 more
europepmc   +1 more source

La enfermedad respiratoria exacerbada por AINE

open access: yes, 2023
Capítulo incluido en el libro: Asma y alergia: la epidemia del siglo XXI. Manuel Alcántara Villar (Coordinador). Sevilla: Universidad Internacional de Andalucía, 2012. ISBN 978-84-7993-227-5.
openaire   +1 more source

Modificaciones en la enseñanza de la enfermedades respiratorias

open access: yesARS Medica, 2018
Sin ...
Rodrigo Moreno Bolton   +3 more
doaj  

Increased Occupational Exposure to Body Fluids in Healthcare Workers During the COVID-19 Pandemic: A Retrospective study from 2013 to 2022

open access: yesRevista de Investigación Clínica
Background: Healthcare workers (HCWs) are at risk of body fluids’ exposure. Objective: The objective of this study was to study the incidence of occupational body fluid exposures in HCW at a tertiary hospital and largest coronavirus disease 2019 (COVID ...
Karla A. Romero-Mora   +6 more
doaj   +1 more source

Impact of Chronic Respiratory Diseases on the Outcomes of COVID-19. [PDF]

open access: yesArch Bronconeumol, 2022
He ZF, Zhong NS, Guan WJ.
europepmc   +1 more source

Glycine by enteral route does not improve major clinical outcomes in severe COVID-19: a randomized clinical pilot trial

open access: yesScientific Reports
There is a worrying scarcity of drug options for patients with severe COVID-19. Glycine possesses anti-inflammatory, cytoprotective, endothelium-protective, and platelet-antiaggregant properties, so its use in these patients seems promising. In this open
Mario H. Vargas   +7 more
doaj   +1 more source

Enhancing quality of life in severe post-COVID-19 survivors through multidisciplinary care

open access: yesERJ Open Research
Background COVID-19 survivors who were hospitalised continue to experience long-term multisystemic sequelae and symptoms, impacting their health-related quality of life (HRQoL).
Daniela Josefina Cataneo-Piña   +19 more
doaj   +1 more source

Respiratory diseases in Peruvian prisons. [PDF]

open access: yesRev Esp Sanid Penit, 2020
Iglesias-Osores S.
europepmc   +1 more source

Home - About - Disclaimer - Privacy